Feature Product:

top gradient

Clinic Trial Information

 

Contact:

MSDS Sheets:

You will need Adobe Acrobat Reader to view PDF documents.

 


Welcome To The Home Of Lloyd Incorporated

LLOYD, Inc. Announces Launch of Butorphic®

Butorphic®, 10mg/mL, a cost-effective option for veterinary analgesia, was launched at Western Veterinary Conference, Las Vegas

Butorphic

LLOYD, Inc. is pleased to announce the introduction of their newest addition to the veterinary injection family of products, Butorphic® (butorphanol tartrate) sterile solution, a staple in veterinary analgesia. Butorphic (10mg/mL) will be packaged in convenient 20 mL, multi-use, vials with an economical price point typically limited to larger 50 mL purchases. “We are proud to introduce yet another key product offering in our line of veterinary sedative and analgesic injections” states LLOYD’s Director of Sales & Marketing, Hoan Tran. “Butorphic will offer veterinarians the quality routine-use opiate they currently purchase at an economic value unavailable in the marketplace today.”

Butorphic® was launched officially at the Western Veterinary Conference in Las Vegas. The product will be available for shipment at the end of March 2010.

Vet-A-Mix

Markets branded pharmaceuticals and nutritional products for use by the veterinary profession.


Lloyd Laboratories

Supplies a family of sterile injections for use in sedation, its reversal, and anesthesia of animals.


Lloyd Pharmaceuticals

Dedicated to manufacturing products for the human pharmaceutical market.

Continuing Education for the Profession

Reference the most recent issues in veterinary medicine today including Small Animal Endocrinology and Equine Metabolic Syndrome as well as other topics of interest.

Your Opinion Counts

Your participation in this survey will help improve our Website! Take our web survey!